Effects of Short-Term Oxycodone Maintenance on Experimental Pain Responses in Physically Dependent Opioid Abusers - 06/10/17
, Paul A. Nuzzo †, Michelle R. Lofwall †, ‡, §, Sharon L. Walsh ∗, †, ‡, §, ¶Abstract |
A common clinical problem with opioid analgesics is the loss of analgesic efficacy after repeated dosing; when this occurs, it is not clear what principles should guide providing effective analgesia among opioid-dependent individuals. This within-subject inpatient study aimed to determine if physically dependent opioid abusers (n = 11) experience changes in oxycodone-induced analgesia during 2 oxycodone maintenance (30 mg orally 4 times per day) phases: initial stabilization (days 1–3) and after 6 weeks of chronic dosing. Six sessions (3 each phase), measured threshold, tolerance, and pain ratings for a Pressure Pain Test and Cold Pressor Test after a single double-blind dose of oxycodone 30 mg (initial stabilization) and 0, 30, and 60 mg (chronic dosing) given in place of a scheduled maintenance dose. Physiologic and opioid agonist effects were assessed during chronic dosing sessions. There was no analgesic response to oxycodone 30 mg. Oxycodone (60 mg) produced a 25% increase in peak Cold Pressor Test threshold compared with placebo, and significantly increased expired breath CO2, miosis, and ratings of abuse liability measures. These data suggest that more than twice the acute oxycodone maintenance dose is needed to produce robust acute analgesia, although adverse effects (eg, respiratory depression and abuse signals) may occur with lower doses.
Perspective |
To understand sensitivity to opioid analgesia in opioid-dependent individuals, this article describes experimental pain, subjective and physiological responses during stabilization and after 6 weeks of oxycodone maintenance. Oxycodone produced euphoric effects and miosis with limited evidence of analgesia.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Persons with opioid dependence underwent pain testing during oxycodone maintenance. |
• | Analgesic testing occurred at stabilization and 6 weeks later. |
• | Oxycodone produced euphoric effects and miosis without robust analgesia. |
• | Differential tolerance is important for treatment of pain and opioid use disorder. |
Key words : Opioid, oxycodone, analgesia, tolerance
Plan
| This work was supported by the National Institute on Drug Abuse (R01 DA016718-04; S.L.W.), (T32 DA01676; M.A.C.); and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (UL1TR000117). |
|
| P.A.N. has received statistical consultant fees from Braeburn Pharmaceuticals and the Behavioral Pharmacology Research Unit, The Johns Hopkins University. M.R.L. has received research funding and consultant fees from Braeburn Pharmaceuticals, consultant fees from Indivior, and honoraria from PCM Scientific for giving educational talks. S.L.W. has served as a consultant to World Meds, Inc, Braeburn Pharmaceuticals, KemPharm, Lightlake Therapeutics, INSYS, Astra Zeneca, Sun Pharma, and Cerecor, Inc, contract research support from Braeburn Pharmaceuticals and Cerecor, Inc, and received speaker and conference chair honoraria from PCM Scientific through an unrestricted educational grant from Indivior. M.A.C. has no conflicts of interest to declare. |
Vol 18 - N° 7
P. 825-834 - juillet 2017 Retour au numéro
Article précédent
- Psychometric Evaluation of the Pain Attitudes Questionnaire-Revised for People With Advanced Cancer
- Kenneth Mah, Kim T. Tran, Lynn R. Gauthier, Gary Rodin, Camilla Zimmermann, David Warr, S. Lawrence Librach, Malcolm Moore, Frances A. Shepherd, Lucia Gagliese
- Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain
- Eva Kosek, Annelie Rosen, Serena Carville, Ernest Choy, Richard H. Gracely, Hanke Marcus, Frank Petzke, Martin Ingvar, Karin B. Jensen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?